Literature DB >> 3315299

Determination of aerobic capacity and the severity of chronic cardiac and circulatory failure.

K T Weber1, J S Janicki, P A McElroy.   

Abstract

The noninvasive determination of maximal oxygen uptake or VO2max, defined as a plateau in VO2 during incremental treadmill exercise, is an objective, reproducible, and negotiable measure of the severity of chronic cardiac or circulatory failure. Moreover, this noninvasive variable predicts the exercise cardiac output response and thereby the cardiac reserve. The lactate or anaerobic threshold has been validated in these patients from the response of mixed venous lactate to incremental exercise and has been shown to be another objective measure of the severity of chronic cardiac or circulatory failure. The anaerobic threshold can be reliably assessed from the response in breath-by-breath respiratory gas exchange by the use of multiple criteria, several of which can be monitored during the exercise test itself and the remainder of which can be measured during the recovery period. We find the breath-by-breath monitoring of respiratory gas exchange and air flow to provide the best means of assessing the anaerobic threshold and for identifying the plateau in VO2, or VO2max, in response to incremental treadmill exercise.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3315299

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

1.  Changes in exercise capacity in subjects with cardiac asymptomatic hereditary hemochromatosis during a follow-up after 5 yrs.

Authors:  Yukitaka Shizukuda; Kevin P Smith; Dorothy J Tripodi; Ross Arena; Yu-Ying Yau; Charles D Bolan; Myron A Waclawiw; Susan F Leitman; Douglas R Rosing
Journal:  Am J Phys Med Rehabil       Date:  2012-05       Impact factor: 2.159

Review 2.  .VO2max: what do we know, and what do we still need to know?

Authors:  Benjamin D Levine
Journal:  J Physiol       Date:  2007-11-15       Impact factor: 5.182

Review 3.  Predicted values of exercise capacity in heart failure: where we are, where to go.

Authors:  Paola Gargiulo; Sergio Olla; Costanza Boiti; Mauro Contini; Pasquale Perrone-Filardi; Piergiuseppe Agostoni
Journal:  Heart Fail Rev       Date:  2014-09       Impact factor: 4.214

4.  Aerobic exercise function of patients with persistent coronary artery aneurysms secondary to Kawasaki disease.

Authors:  J Rhodes; Z M Hijazi; G R Marx; D R Fulton
Journal:  Pediatr Cardiol       Date:  1996 Jul-Aug       Impact factor: 1.655

Review 5.  Stress testing. Directions for the future.

Authors:  C Foster
Journal:  Sports Med       Date:  1988-07       Impact factor: 11.136

6.  Defining the optimal prognostic window for cardiopulmonary exercise testing in patients with heart failure.

Authors:  Ross Arena; Jonathan Myers; Joshua Abella; Sherry Pinkstaff; Peter Brubaker; Dalane Kitzman; Mary Ann Peberdy; Daniel Bensimhon; Paul Chase; Daniel E Forman; Marco Guazzi
Journal:  Circ Heart Fail       Date:  2010-03-03       Impact factor: 8.790

7.  Peak oxygen uptake in relation to total heart volume discriminates heart failure patients from healthy volunteers and athletes.

Authors:  Henrik Engblom; Katarina Steding; Marcus Carlsson; Henrik Mosén; Bo Hedén; Torsten Buhre; Björn Ekmehag; Håkan Arheden
Journal:  J Cardiovasc Magn Reson       Date:  2010-12-16       Impact factor: 5.364

8.  MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study.

Authors:  Effrosyni D Manali; Panagiotis Lyberopoulos; Christina Triantafillidou; Likourgos F Kolilekas; Christina Sotiropoulou; Joseph Milic-Emili; Charis Roussos; Spyros A Papiris
Journal:  BMC Pulm Med       Date:  2010-05-28       Impact factor: 3.317

9.  The relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancer.

Authors:  C H Richards; E F Leitch; P G Horgan; J H Anderson; R F McKee; D C McMillan
Journal:  Br J Cancer       Date:  2010-09-28       Impact factor: 7.640

10.  N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea.

Authors:  Micha T Maeder; Peter Ammann; Hans Rickli; Otto D Schoch; Wolfgang Korte; Christoph Hürny; Jonathan Myers; Thomas Münzer
Journal:  Sleep Breath       Date:  2008-03       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.